# Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences

> **NCT05997732** · PHASE4 · RECRUITING · sponsor: **University of Alberta** · enrollment: 30 (estimated)

## Conditions studied

- Vasoconstriction
- Vasodilation

## Interventions

- **DRUG:** Phenylephrine Hydrochloride
- **DRUG:** Isoproterenol Hydrochloride
- **DRUG:** Norepinephrine Bitartrate
- **DRUG:** Propranolol Hydrochloride
- **DRUG:** Phentolamine Mesylate
- **DRUG:** Phenylephrine Hydrochloride
- **DRUG:** Isoproterenol Hydrochloride
- **DRUG:** Propranolol Hydrochloride

## Key facts

- **NCT ID:** NCT05997732
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-31
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05997732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05997732, "Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05997732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*